Psyence Biomedical Ltd. (PBM )

Currency in USD Disclaimer
$3.18 +$0.72 (29.27%)
Closed 12/20/2024
$2.78
$4.25
$1.51
$945.15

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol PBM
  • Company Psyence Biomedical Ltd.
  • Price $3.18
  • Changes Percentage 29.27
  • Change 0.72
  • Day Low $2.78
  • Day High $4.25
  • Year High $945.15
  • Year Low $1.51
  • Market Cap $2,687,291
  • Price Avg 50 EMA (D) $4.76
  • Price Avg 200 EMA (D) $36.9
  • Exchange NASDAQ
  • Volume 23,607,619
  • Average Volume 1,959,645
  • Open $3.93
  • Previous Close $2.46
  • EPS -586.5
  • PE -0.01
  • Earnings Announcement 1970-01-01 00:00:00
  • Shares Outstanding $845,060

Company brief: PSYENCE BIOMEDICAL LTD. (PBM )

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

PBM Corporation News

Income Statement